Oregon Oncology to integrate Deep Lens’ clinical trial platform 19 Apr 2021 (Last Updated April 19th, 2021 17:27) Oregon Oncology Specialists has signed a strategic collaboration to integrate a Deep Lens’ artificial-intelligence (AI)-based clinical trial screening platform to expand patient access to clinical trials. Share Article Oregon Oncology Specialists has signed a strategic collaboration to integrate a Deep Lens’ artificial-intelligence (AI)-based clinical trial screening platform to expand patient access to clinical trials. Under the partnership, Oregon Oncology will integrate VIPER into its community oncology practice network. The platform will be integrated directly to Oregon Oncology Specialists EMR (iKnowMed), molecular data feeds (Guardant Health and Foundation Medicine), and pathology feeds for the automatic identification of qualified patients for clinical trials.